India drug regulator finds counterfeit medicines worth 20 million rupees in raid
INDIA’S drug regulator recovered counterfeit medicines worth more than 20 million rupees (S$323,982) after a raid last month in the eastern city of Kolkata, the federal health ministry said on Thursday (Aug 3).
The raid, carried out by the Central Drugs Standard Control Organisation, found counterfeit copies of leading brands by manufacturers like Cipla, Sun Pharma and Alkem Laboratories, the health ministry said.
One person was arrested, it added.
“Further investigation to find the manufacturer and supply chain is ongoing to ensure (the) supply of genuine medicine for consumption of (the) general public,” the health ministry said.
The medicines recovered included copies of acid reflux drugs like Pan-D and Pantocid DSR, manufactured by Alkem and Sun Pharma, respectively, as well as Urimax-D, a medicine to treat an enlarged prostrate gland, made by Cipla.
Authorities also recovered counterfeit copies of antibiotic medicines Augmentin and Clavam.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
“(Narendra) Modi’s government will not make any kind of compromise to stop adulterated medicines,” health minister Mansukh Mandaviya said on X, while congratulating the officers who carried out the raid.
The raid was the result of an investigation that began in January this year, following a complaint from Sun Pharma when authorities recovered counterfeit medicines worth one million rupees, the health ministry said. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
From post-war hardships to ‘era of national rise’: Vietnam’s family firms face first succession test
‘We’re not a bubble tea brand’: Chagee aims to double Asia-Pacific footprint to 600 stores by 2027